← Eichor
Study identifier: NCT04877522 Synced from ClinicalTrials.gov · July 28, 2026
● Recruiting

Asciminib Roll-over Study

Condition: Chronic Myelogenous Leukemia · Leukemia, Myelogenous, Chronic, BCR-ABL Positive  ·  Sponsor: Novartis Pharmaceuticals

PhasePhase 4
Planned participants347
Who can joinAll sexes, 7 Years to 100 Years
Healthy volunteersNo

About this study

This is a long term safety study for patients who have completed a Novartis sponsored asciminib study and are judged by the investigator to benefit from continued treatment

This description comes directly from the study's public registry record.

Talk to the study team

Novartis Pharmaceuticals  ·  1-888-669-6682  ·  novartis.email@novartis.com

Novartis Pharmaceuticals  ·  +41613241111

Always discuss trial participation with your own doctor first.

Locations (85)

Michigan Med University of MichiganAnn Arbor, Michigan, United StatesRecruiting
Memorial Sloan KetteringNew York, New York, United StatesRecruiting
Oregon Health Sciences UniversityPortland, Oregon, United StatesActive Not Recruiting
Texas OncologyDallas, Texas, United StatesRecruiting
Uni Of TX MD Anderson Cancer CntrHouston, Texas, United StatesRecruiting
Medical College of WisconsinMilwaukee, Wisconsin, United StatesRecruiting
Novartis Investigative SiteCABA, Buenos Aires, ArgentinaRecruiting
Novartis Investigative SiteCapital Federal, ArgentinaRecruiting
Novartis Investigative SiteGraz, AustriaRecruiting
Novartis Investigative SiteVienna, AustriaRecruiting
Novartis Investigative SiteRio de Janeiro, Rio de Janeiro, BrazilCompleted
Novartis Investigative SiteSão Paulo, São Paulo, BrazilCompleted

+ 73 more locations — full list on the registry record.

Follow this study

Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.

We email about this public record only. Unsubscribe anytime with one click. Never medical advice.

Is this your study? This page was generated automatically from the public registry record. Sponsors can claim it — free — to add branding and verified contact routing. Claim this page →

This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.

Source record: clinicaltrials.gov/study/NCT04877522